Nobivac Feline 1-HCPCh (Eclipse 4) - 25x1Doses

MFR
Merck
Share
Login to earn Rewards for sharing!

Nobivac® Feline 1-HCPCh (Eclipse 4) is recommended for the vaccination of healthy cats against diseases caused by feline Rhinotracheitis (feline Herpes), Calici, Panleukopenia, and Chlamydia Psittaci. Has been shown to block the replication of canine Parvovirus in cats. This vaccine goes beyond the core antigen protection to help prevent feline Chlamydophila infection. Optimal for healthy outdoor cats or cats that board frequently. Non-adjuvanted formula. Modified live viruses and bacteria. Recommended for use in healthy cats nine weeks of age or older.

SKU
007415

Shipping : Perishable

$93.99
-
+

Intervet/Merck Animal Health

FELINE RHINOTRACHEITIS-CALICI-PANLEUKOPENIA-CHLAMYDIA PSITTACI VACCINE Modified Live Virus and Chlamydia

FOR ANIMAL USE ONLY

IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.

THIMEROSAL FREE

INDICATIONS: This product has been shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, panleukopenia viruses and Chlamydia psittaci. Duration of Immunity has not been established. To review efficacy and safety data, go to productdata.aphis.usda.gov.

DOSAGE AND ADMINISTRATION: Transfer contents of the diluent vial to the Nobivac® Feline 1-HCPCh vial aseptically. Mix gently until dissolved.

Two doses are required for primary immunization.

Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.

Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.

The presence of maternal antibodies is known to interfere with the development of active immunity in cats and additional boosters will be required in most young animals. Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For more information on revaccination frequency, in general or in the face of maternal antibody, consult your veterinarian or the manufacturer.

PRECAUTIONS:

• Store at 2° - 8°C (35°-46°F).

• Do not freeze.

• Use new, non-chemically sterilized needles and syringes.

• Do not mix with other products, except as specified on the label.

• Inactivate unused contents before disposal.

• In case of human exposure, contact a physician.

WARNINGS:

• Contains gentamicin as a preservative.

• Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.

• Do not vaccinate pregnant cats.

• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

More Information
Directions

Transfer contents of the diluent vial to the Nobivac®: Feline 1-HCPCh vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Two doses are required for primary immunization.

Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.

Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination. Annual revaccination with one dose is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.

Write Your Own Review
You're reviewing:Nobivac Feline 1-HCPCh (Eclipse 4) - 25x1Doses
Your Rating
There are no any videos in this product.